Most sporadic colorectal tumors arise through a specific series of mutations, termed the adenoma-carcinoma sequence, beginning with APC, and followed by mutations in tumor suppressors such as p53 (60–70%) or oncogenes such as KRAS (40%) that enable transformation (77). This evidence concerns the gene APC and neoplasm.